帕利哌酮缓释片对精神分裂症社会功能的独立影响：超越其对阳性和阴性症状的作用——一项中介分析 - Suppr

Suppr

超能文献

Independent effect of paliperidone extended release on social functioning beyond its effect on positive and negative symptoms of schizophrenia: a mediation analysis.

作者信息

Hough David, Nuamah Isaac F, Lim Pilar, Sampson Allan, Gagnon Dennis D, Rothman Margaret

出版信息

J Clin Psychopharmacol. 2009 Oct;29(5):496-7. doi: 10.1097/JCP.0b013e3181b5f40b.

DOI:10.1097/JCP.0b013e3181b5f40b

PMID:19745652

Abstract

摘要

相似文献

Independent effect of paliperidone extended release on social functioning beyond its effect on positive and negative symptoms of schizophrenia: a mediation analysis.帕利哌酮缓释片对精神分裂症社会功能的独立影响：超越其对阳性和阴性症状的作用——一项中介分析

J Clin Psychopharmacol. 2009 Oct;29(5):496-7. doi: 10.1097/JCP.0b013e3181b5f40b.

[Efficacy of paliperidone extended-release tablets in the improvement of social functions in schizophrenics: a randomized and controlled study].帕利哌酮缓释片改善精神分裂症患者社会功能的疗效：一项随机对照研究

Zhonghua Yi Xue Za Zhi. 2010 Aug 3;90(29):2030-5.

Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies.口服帕利哌酮缓释片治疗急性精神分裂症的疗效与安全性：三项52周开放性研究的汇总数据

Int Clin Psychopharmacol. 2008 Nov;23(6):343-56. doi: 10.1097/YIC.0b013e328314e1f3.

A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.一项双盲、安慰剂对照、随机研究，评估帕利哌酮缓释片对精神分裂症患者睡眠结构的影响。

Int Clin Psychopharmacol. 2007 Sep;22(5):299-308. doi: 10.1097/YIC.0b013e3281c55f4f.

Paliperidone extended-release: a review of efficacy and tolerability in schizophrenia, schizoaffective disorder and bipolar mania.帕利哌酮长效：在精神分裂症、分裂情感障碍和双相躁狂中的疗效和耐受性的综述。

Expert Opin Pharmacother. 2010 Oct;11(15):2557-67. doi: 10.1517/14656566.2010.495387.

Effectiveness of paliperidone extended-release for patients with schizophrenia: focus on subjective improvement.帕利哌酮缓释片对精神分裂症患者的疗效：聚焦主观改善

Hum Psychopharmacol. 2013 Mar;28(2):107-16. doi: 10.1002/hup.2284. Epub 2013 Feb 18.

Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.帕利哌酮缓释片预防精神分裂症患者症状复发的随机、双盲、安慰剂对照研究。

J Clin Psychopharmacol. 2007 Feb;27(1):6-14. doi: 10.1097/JCP.0b013e31802dda4a.

Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study.帕利哌酮缓释片的疗效与安全性：一项为期6周的随机、安慰剂对照研究结果

Biol Psychiatry. 2007 Dec 15;62(12):1363-70. doi: 10.1016/j.biopsych.2007.01.017. Epub 2007 Jun 28.

Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension.口服帕利哌酮缓释片在老年精神分裂症患者中的安全性和耐受性：一项为期六个月开放标签扩展的双盲、安慰剂对照研究。

Am J Geriatr Psychiatry. 2008 Jan;16(1):31-43. doi: 10.1097/JGP.0b013e31815a3e7a.

Hospitalization rates before and after initiation of paliperidone ER in patients with schizophrenia: results from open-label extensions of the US double-blind trials.精神分裂症患者起始使用帕利哌酮缓释片前后的住院率：美国双盲试验开放标签延长期的结果

Curr Med Res Opin. 2008 Jun;24(6):1807-15. doi: 10.1185/03007990802119368.

引用本文的文献

Relationship between clinical outcomes measures and personal and social performance functioning in a prospective, interventional study in schizophrenia.在一项针对精神分裂症的前瞻性干预研究中，临床结局测量与个人和社会功能表现之间的关系。

Int J Methods Psychiatr Res. 2021 Jun;30(2):e1855. doi: 10.1002/mpr.1855. Epub 2020 Dec 23.

Switching to paliperidone extended release in patients with schizophrenia dissatisfied with previous olanzapine treatment: Post hoc analysis of an open-label, prospective study.对先前奥氮平治疗不满意的精神分裂症患者换用帕利哌酮缓释片：一项开放标签前瞻性研究的事后分析

Medicine (Baltimore). 2019 Jan;98(3):e13688. doi: 10.1097/MD.0000000000013688.

Paliperidone Palmitate Improves and Maintains Functioning in Asia-Pacific Patients with Schizophrenia.棕榈酸帕利哌酮可改善和维持亚太地区精神分裂症患者的功能。

Adv Ther. 2017 Nov;34(11):2503-2517. doi: 10.1007/s12325-017-0638-0. Epub 2017 Nov 3.

Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study.每月一次注射棕榈酸帕利哌酮治疗急性加重期亚洲住院精神分裂症患者的疗效与安全性：一项开放标签、前瞻性、非对照研究

Neuropsychiatr Dis Treat. 2015 Dec 21;12:15-24. doi: 10.2147/NDT.S83651. eCollection 2016.

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia.在精神分裂症患者中使用帕利哌酮缓释片进行自然主义治疗的社会功能结局。

Neuropsychiatr Dis Treat. 2015 Jun 22;11:1511-21. doi: 10.2147/NDT.S85891. eCollection 2015.

Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia.希腊精神分裂症患者样本中个人与社会表现量表（PSP）与阳性和阴性症状量表（PANSS）之间的相关性。

BMC Psychiatry. 2014 Jul 8;14:197. doi: 10.1186/1471-244X-14-197.

Safety and efficacy of paliperidone extended-release in acute and maintenance treatment of schizophrenia.帕利哌酮缓释片在精神分裂症急性治疗和维持治疗中的安全性与有效性。

J Cent Nerv Syst Dis. 2011 Feb 14;3:27-41. doi: 10.4137/JCNSD.S1607. Print 2011.

The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia.新型非典型抗精神病药物对精神分裂症患者报告结局的影响。

CNS Drugs. 2013 Aug;27(8):625-36. doi: 10.1007/s40263-013-0070-1.

Effects of paliperidone extended release on the symptoms and functioning of schizophrenia.帕利哌酮缓释片对精神分裂症症状及功能的影响。

BMC Clin Pharmacol. 2012 Jan 6;12:1. doi: 10.1186/1472-6904-12-1.

Paliperidone extended release: a review of its use in the management of schizophrenia.帕利哌酮长效制剂：在精神分裂症治疗中的应用评价。

Drugs. 2010 Jul 9;70(10):1295-317. doi: 10.2165/11204840-000000000-00000.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验